flow trial semaglutide kidney outcomes hazard ratio 0.76 nejm 2024 Ozempic® (semaglutide injection) Semaglutides Are Poised to Remake

The right dosage depends on your goals, body type, and how your system responds

As of March 2025, 11 states cover GLP-1s for weight loss under their state employee health plan, nine states provide coverage under their state Medicaid program, and five states provide coverage under both programs

The dosing regimen often starts with a lower dose to allow the body to adjust, reducing the likelihood of side effects such as nausea

Final Thoughts Switching from semaglutide to tirzepatide is one of the more common transitions in GLP-1 therapyand for some people, its a logical next step when progress stalls or goals shift

AITC also decreased proinflammatory cytokines while increasing Nrf2, neural outgrowth and regeneration marker growth-associated protein 43 (GAP43), and neurogenesis-associated neural cell adhesion molecule levels (117)

Centenarians have plasma MOTS-c levels resembling those of people decades younger, suggesting preserved mitochondrial signaling is a feature of exceptional aging